SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001104659-23-024007
Filing Date
2023-02-22
Accepted
2023-02-22 06:33:58
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A tm237515d1_sc14d9a.htm SC 14D9/A 26776
2 EXHIBIT 99.(A)(5)(M) tm237515d1_ex99-a5m.htm EX-99.(A)(5)(M) 16868
3 GRAPHIC tm237515d1_ex99a5mimge001.jpg GRAPHIC 5257
4 GRAPHIC tm237515d1_ex99a5mimge002.jpg GRAPHIC 4072
  Complete submission text file 0001104659-23-024007.txt   58624
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filed by) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Subject) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-83386 | Film No.: 23650477
SIC: 2834 Pharmaceutical Preparations